Clinical trial
Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate…
NCT00002874 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002874 |
|---|---|
| Title | Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy |
| Official title | A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR pT3N0 CARCINOMA OF THE PROSTATE |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | bicalutamide, radiation therapy, placebo |
| Enrollment | 840 |
| Start date | Feb 1, 1998 |
| Primary completion | Aug 1, 2015 |
| Completion | May 20, 2022 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2022 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: